CEL SCI CORP (CVM)
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
Global Credit Union selects NCR Atleos ATMs to support new Utqiaġvik branch in Alaska’s northernmost city
Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets
Sanuwave Health Updates Second Quarter 2026 Guidance
Pennymac Names AWS as Preferred Cloud Provider, Expanding Strategic Agreement to Deploy Enterprise-Grade AI and Commercialize its Servicing Platform
ONE Nuclear Announces Strategic Collaboration with Sunshine Partners to Develop Joint Power Projects in West Texas
Digimarc Extends Its Agent-Native Provenance and Verification Platform to the World’s Leading Agentic AI Ecosystems
Abrams Capital Disposes of Shares of SECURE Waste Infrastructure Corp.
Yum! Brands, Inc. Enters into Agreements to Sell Pizza Hut for $2.7 Billion
U.S. Bank Wealth Management Appoints Daniel Farley Chief Investment Officer